Device Trial Radar · NCT03300206
A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
Last checked: Nov 19, 2026Latest source record: Dec 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
525
Actual
Start
Sep 13, 2017
Primary completion
Mar 19, 2019
Study completion Mar 19, 2019
Sponsor
- Lead sponsor
- Hologic, Inc.Public (HOLX)
- Sponsor type
- Industry
- First posted
- Oct 3, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current standard-of-care breast biopsy procedures
Conditions
- Breast Cancer Female
Interventions
Breast BiopsyDevice
A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is a diagnostic procedure that can definitely determine if the suspicious area is cancerous.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in Procedural Time in MinutesTime frame: Average Time- Procedure (1 Lesion per subject): Total Time elapsed from when the subject enters the procedure room until they have left the procedure room, an average of 43 minutes.
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
HonorHealth
Phoenix, Arizona
Kensington Medical Center - Kaiser Permanente
Kensington, Maryland
Washington University
St Louis, Missouri
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.